Header Logo

Connection

Theodore Pincus to Arthritis, Rheumatoid

Back to Details
This is a "connection" page, showing publications Theodore Pincus has written about Arthritis, Rheumatoid.
Theodore Pincus
Connection Strength
25.934
Arthritis, Rheumatoid
  1. Should Quantitative Measures and Management of Rheumatoid Arthritis Include More Than Control of Inflammatory Activity? J Rheumatol. 2022 Mar; 49(3):336-338.
    View in: PubMed
    Score: 0.621
  2. Comment on: 'It can't be zero!' Difficulties in completing patient global assessment in rheumatoid arthritis: a mixed methods study. Rheumatology (Oxford). 2021 01 05; 60(1):e28-e29.
    View in: PubMed
    Score: 0.589
  3. Multidimensional Health Assessment Questionnaire as an Effective Tool to Screen for Depression in Routine Rheumatology Care. Arthritis Care Res (Hoboken). 2021 01; 73(1):120-129.
    View in: PubMed
    Score: 0.588
  4. Long-term Glucocorticoid Use in Rheumatoid Arthritis. J Rheumatol. 2021 08; 48(8):1342.
    View in: PubMed
    Score: 0.580
  5. Osteoarthritis is as severe as rheumatoid arthritis: evidence over 40 years according to the same measure in each disease. Clin Exp Rheumatol. 2019 Sep-Oct; 37 Suppl 120(5):7-17.
    View in: PubMed
    Score: 0.541
  6. Disease Burden in Osteoarthritis Is Similar to That of Rheumatoid Arthritis at Initial Rheumatology Visit and Significantly Greater Six Months Later. Arthritis Rheumatol. 2019 08; 71(8):1276-1284.
    View in: PubMed
    Score: 0.530
  7. Minimal Clinically Important Improvement of Routine Assessment of Patient Index Data 3 in Rheumatoid Arthritis. J Rheumatol. 2019 01; 46(1):27-30.
    View in: PubMed
    Score: 0.505
  8. Assessment of pain and other patient symptoms in routine clinical care as quantitative, standardised, "scientific" data. Clin Exp Rheumatol. 2017 Sep-Oct; 35 Suppl 107(5):13-20.
    View in: PubMed
    Score: 0.469
  9. Pain and other self-report scores in patients with osteoarthritis indicate generally similar disease burden to patients with rheumatoid arthritis. Clin Exp Rheumatol. 2017 Sep-Oct; 35 Suppl 107(5):88-93.
    View in: PubMed
    Score: 0.469
  10. Limited Value of the Multi-Biomarker Disease Activity Assay Compared to the Routine Assessment of Patient Index Data 3 (RAPID3) Score in the Prognosis of Important Clinical Outcomes in Rheumatoid Arthritis: Comment on the Article by Fleischmann et al and Accompanying Editorial by Davis. Arthritis Rheumatol. 2017 04; 69(4):866-867.
    View in: PubMed
    Score: 0.451
  11. Electronic eRAPID3 (Routine Assessment of Patient Index Data): opportunities and complexities. Clin Exp Rheumatol. 2016 Sep-Oct; 34(5 Suppl 101):S49-S53.
    View in: PubMed
    Score: 0.440
  12. Limitations of clinical trials in chronic diseases: is the efficacy of methotrexate (MTX) underestimated in polyarticular psoriatic arthritis on the basis of limitations of clinical trials more than on limitations of MTX, as was seen in rheumatoid arthritis? Clin Exp Rheumatol. 2015 Sep-Oct; 33(5 Suppl 93):S82-93.
    View in: PubMed
    Score: 0.410
  13. Rheumatoid arthritis: Predicting mortality in RA: the quest for useful information. Nat Rev Rheumatol. 2015 Sep; 11(9):507-9.
    View in: PubMed
    Score: 0.402
  14. Circadian use of glucocorticoids in rheumatoid arthritis. Neuroimmunomodulation. 2015; 22(1-2):33-9.
    View in: PubMed
    Score: 0.380
  15. Clinical trials documenting the efficacy of low-dose glucocorticoids in rheumatoid arthritis. Neuroimmunomodulation. 2015; 22(1-2):46-50.
    View in: PubMed
    Score: 0.380
  16. The past versus the present, 1980-2004: reduction of mean initial low-dose, long-term glucocorticoid therapy in rheumatoid arthritis from 10.3 to 3.6 mg/day, concomitant with early methotrexate, with long-term effectiveness and safety of less than 5 mg/day. Neuroimmunomodulation. 2015; 22(1-2):89-103.
    View in: PubMed
    Score: 0.380
  17. Is a patient questionnaire without a joint examination as undesirable as a joint examination without a patient questionnaire? J Rheumatol. 2014 Apr; 41(4):619-21.
    View in: PubMed
    Score: 0.368
  18. Assessing remission in rheumatoid arthritis on the basis of patient reported outcomes--advantages of using RAPID3/MDHAQ in routine care. Bull Hosp Jt Dis (2013). 2014; 72(2):136-41.
    View in: PubMed
    Score: 0.362
  19. Documenting the value of care for rheumatoid arthritis, analogous to hypertension, diabetes, and hyperlipidemia: is control of individual patient self-report measures of global estimate and physical function more valuable than laboratory tests, radiographs, indices, or remission criteria? J Rheumatol. 2013 Sep; 40(9):1469-74.
    View in: PubMed
    Score: 0.354
  20. Decline of mean initial prednisone dosage from 10.3 to 3.6 mg/day to treat rheumatoid arthritis between 1980 and 2004 in one clinical setting, with long-term effectiveness of dosages less than 5 mg/day. Arthritis Care Res (Hoboken). 2013 May; 65(5):729-36.
    View in: PubMed
    Score: 0.346
  21. Patient self-report RADAI (Rheumatoid Arthritis Disease Activity Index) joint counts on an MDHAQ (Multidimensional Health Assessment Questionnaire) in usual care of consecutive patients with rheumatic diseases other than rheumatoid arthritis. Arthritis Care Res (Hoboken). 2013 Feb; 65(2):288-93.
    View in: PubMed
    Score: 0.340
  22. Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort. J Rheumatol. 2013 Apr; 40(4):386-93.
    View in: PubMed
    Score: 0.340
  23. RAPID3, an index of only 3 patient self-report core data set measures, but not ESR, recognizes incomplete responses to methotrexate in usual care of patients with rheumatoid arthritis. Bull Hosp Jt Dis (2013). 2013; 71(2):117-20.
    View in: PubMed
    Score: 0.338
  24. Update on methotrexate as the anchor drug for rheumatoid arthritis. Bull Hosp Jt Dis (2013). 2013; 71 Suppl 1:S9-19.
    View in: PubMed
    Score: 0.338
  25. Evidence that the strategy is more important than the agent to treat rheumatoid arthritis. Data from clinical trials of combinations of non-biologic DMARDs, with protocol-driven intensification of therapy for tight control or treat-to-target. Bull Hosp Jt Dis (2013). 2013; 71 Suppl 1:S33-40.
    View in: PubMed
    Score: 0.338
  26. Treat-to-target: not as simple as it appears. Clin Exp Rheumatol. 2012 Jul-Aug; 30(4 Suppl 73):S10-20.
    View in: PubMed
    Score: 0.333
  27. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis. Ann Intern Med. 2012 Aug 21; 157(4):299; author reply 300.
    View in: PubMed
    Score: 0.330
  28. Importance of patient history and physical examination in rheumatoid arthritis compared to other chronic diseases: results of a physician survey. Arthritis Care Res (Hoboken). 2012 Aug; 64(8):1250-5.
    View in: PubMed
    Score: 0.328
  29. An evidence-based medical visit for patients with rheumatoid arthritis based on standard, quantitative scientific data from a patient MDHAQ and physician report. Bull NYU Hosp Jt Dis. 2012; 70(2):73-94.
    View in: PubMed
    Score: 0.315
  30. Effective initial and long-term prednisone in doses of less than 5 mg/day to treat rheumatoid arthritis--documentation using a patient self-report Multidimensional Health Assessment Questionnaire (MDHAQ). Bull NYU Hosp Jt Dis. 2012; 70 Suppl 1:14-20.
    View in: PubMed
    Score: 0.315
  31. Pragmatic and scientific advantages of MDHAQ/ RAPID3 completion by all patients at all visits in routine clinical care. Bull NYU Hosp Jt Dis. 2012; 70 Suppl 1:30-6.
    View in: PubMed
    Score: 0.315
  32. RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: Similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damage) clinical trial of certolizumab pegol. Arthritis Care Res (Hoboken). 2011 Aug; 63(8):1142-9.
    View in: PubMed
    Score: 0.306
  33. Differences in treat-to-target in patients with rheumatoid arthritis versus hypertension and diabetes--consequences for clinical care. Bull NYU Hosp Jt Dis. 2011; 69(2):104-10.
    View in: PubMed
    Score: 0.294
  34. In the clinic. Rheumatoid arthritis. Ann Intern Med. 2010 Jul 06; 153(1):ITC1-1-ITC1-15; quiz ITC1-16.
    View in: PubMed
    Score: 0.284
  35. Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis. Rheumatology (Oxford). 2010 Sep; 49(9):1795-6; author reply 1796-7.
    View in: PubMed
    Score: 0.282
  36. RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds. Arthritis Care Res (Hoboken). 2010 Feb; 62(2):181-9.
    View in: PubMed
    Score: 0.276
  37. Complexities in assessment of rheumatoid arthritis: absence of a single gold standard measure. Rheum Dis Clin North Am. 2009 Nov; 35(4):687-97, v.
    View in: PubMed
    Score: 0.271
  38. A biopsychosocial model to complement a biomedical model: patient questionnaire data and socioeconomic status usually are more significant than laboratory tests and imaging studies in prognosis of rheumatoid arthritis. Rheum Dis Clin North Am. 2009 Nov; 35(4):699-712, v.
    View in: PubMed
    Score: 0.271
  39. Joint counts to assess rheumatoid arthritis for clinical research and usual clinical care: advantages and limitations. Rheum Dis Clin North Am. 2009 Nov; 35(4):713-22, v-vi.
    View in: PubMed
    Score: 0.271
  40. Radiographic measures to assess patients with rheumatoid arthritis: advantages and limitations. Rheum Dis Clin North Am. 2009 Nov; 35(4):723-9, vi.
    View in: PubMed
    Score: 0.271
  41. Laboratory tests to assess patients with rheumatoid arthritis: advantages and limitations. Rheum Dis Clin North Am. 2009 Nov; 35(4):731-4, vi-vii.
    View in: PubMed
    Score: 0.271
  42. Patient questionnaires in rheumatoid arthritis: advantages and limitations as a quantitative, standardized scientific medical history. Rheum Dis Clin North Am. 2009 Nov; 35(4):735-43, vii.
    View in: PubMed
    Score: 0.271
  43. RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care. Rheum Dis Clin North Am. 2009 Nov; 35(4):773-8, viii.
    View in: PubMed
    Score: 0.271
  44. Criterion contamination of depression scales in patients with rheumatoid arthritis: the need for interpretation of patient questionnaires (as all clinical measures) in the context of all information about the patient. Rheum Dis Clin North Am. 2009 Nov; 35(4):861-4, xi-xii.
    View in: PubMed
    Score: 0.271
  45. Management of associated rheumatoid arthritis and fibromyalgia. J Rheumatol. 2009 Sep; 36(9):2123-4; discussion 2124-5.
    View in: PubMed
    Score: 0.268
  46. Rheumatoid arthritis: strategy more important than agent. Lancet. 2009 Aug 08; 374(9688):430-2.
    View in: PubMed
    Score: 0.267
  47. Is a self-report RAPID3 score a reasonable alternative to a DAS28 in usual clinical care? J Clin Rheumatol. 2009 Aug; 15(5):215-7.
    View in: PubMed
    Score: 0.267
  48. Quantitative clinical rheumatology: why is a test for anti-CCP antibodies included in most routine care for rheumatoid arthritis while a HAQ/MDHAQ remains largely a research tool? J Rheumatol. 2009 Aug; 36(8):1563-4.
    View in: PubMed
    Score: 0.267
  49. Declines in erythrocyte sedimentation rates in patients with rheumatoid arthritis over the second half of the 20th century. J Rheumatol. 2009 Aug; 36(8):1596-9.
    View in: PubMed
    Score: 0.264
  50. Quantitative clinical rheumatology: "keep it simple, stupid": MDHAQ function, pain, global, and RAPID3 quantitative scores to improve and document the quality of rheumatologic care. J Rheumatol. 2009 Jun; 36(6):1099-100.
    View in: PubMed
    Score: 0.264
  51. Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States. J Rheumatol. 2009 Jul; 36(7):1387-90.
    View in: PubMed
    Score: 0.262
  52. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories. J Rheumatol. 2008 Nov; 35(11):2136-47.
    View in: PubMed
    Score: 0.251
  53. Are excellent systematic reviews of clinical trials useful for patient care? Nat Clin Pract Rheumatol. 2008 Jun; 4(6):294-5.
    View in: PubMed
    Score: 0.245
  54. Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs. Mod Rheumatol. 2008; 18(3):228-39.
    View in: PubMed
    Score: 0.244
  55. Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores. J Rheumatol. 2008 Apr; 35(4):603-9.
    View in: PubMed
    Score: 0.242
  56. Limitations of a quantitative swollen and tender joint count to assess and monitor patients with rheumatoid arthritis. Bull NYU Hosp Jt Dis. 2008; 66(3):216-23.
    View in: PubMed
    Score: 0.239
  57. A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10-20 seconds for use in standard clinical care, without rulers, calculators, websites or computers. Best Pract Res Clin Rheumatol. 2007 Aug; 21(4):755-87.
    View in: PubMed
    Score: 0.232
  58. A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative routine assessment of patient index data (RAPID) scores on a multidimensional health assessment questionnaire (MDHAQ). Best Pract Res Clin Rheumatol. 2007 Aug; 21(4):789-804.
    View in: PubMed
    Score: 0.232
  59. N-of-1 trial of low-dose methotrexate and/or prednisolone in lieu of anti-CCP, MRI, or ultrasound, as first option in suspected rheumatoid arthritis? J Rheumatol. 2007 Feb; 34(2):250-2.
    View in: PubMed
    Score: 0.224
  60. Patient questionnaires and formal education as more significant prognostic markers than radiographs or laboratory tests for rheumatoid arthritis mortality--limitations of a biomedical model to predict long-term outcomes. Bull NYU Hosp Jt Dis. 2007; 65 Suppl 1:S29-36.
    View in: PubMed
    Score: 0.223
  61. Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trials. J Rheumatol. 2006 Dec; 33(12):2372-5.
    View in: PubMed
    Score: 0.222
  62. Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population. Arthritis Rheum. 2006 Oct; 54(10):3113-8.
    View in: PubMed
    Score: 0.219
  63. The DAS is the most specific measure, but a patient questionnaire is the most informative measure to assess rheumatoid arthritis. J Rheumatol. 2006 May; 33(5):834-7.
    View in: PubMed
    Score: 0.213
  64. Advantages and limitations of quantitative measures to assess rheumatoid arthritis: joint counts, radiographs, laboratory tests, and patient questionnaires. Bull NYU Hosp Jt Dis. 2006; 64(1-2):32-9.
    View in: PubMed
    Score: 0.208
  65. Radiographic benefit without clinical improvement in infliximab-treated patients with rheumatoid arthritis: comment on the article by Smolen et al. Arthritis Rheum. 2005 Dec; 52(12):4044-5; author reply 4045-7.
    View in: PubMed
    Score: 0.207
  66. Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria. Arthritis Rheum. 2005 Apr; 52(4):1031-6.
    View in: PubMed
    Score: 0.197
  67. Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis Rheum. 2005 Apr; 52(4):1009-19.
    View in: PubMed
    Score: 0.197
  68. Quantitative measures and indices to assess rheumatoid arthritis in clinical trials and clinical care. Rheum Dis Clin North Am. 2004 Nov; 30(4):725-51, vi.
    View in: PubMed
    Score: 0.192
  69. Making an impact on mortality in rheumatoid arthritis: targeting cardiovascular comorbidity. Arthritis Rheum. 2004 Jun; 50(6):1734-9.
    View in: PubMed
    Score: 0.186
  70. Add-on or step-up trials in rheumatoid arthritis: comment on the article by Boers. Arthritis Rheum. 2004 Apr; 50(4):1351; author reply 1351-2.
    View in: PubMed
    Score: 0.184
  71. Patient questionnaires and formal education level as prospective predictors of mortality over 10 years in 97% of 1416 patients with rheumatoid arthritis from 15 United States private practices. J Rheumatol. 2004 Feb; 31(2):229-34.
    View in: PubMed
    Score: 0.182
  72. Guidelines for monitoring of methotrexate therapy: "evidence-based medicine" outside of clinical trials. Arthritis Rheum. 2003 Oct; 48(10):2706-9.
    View in: PubMed
    Score: 0.178
  73. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission. J Rheumatol. 2003 Jun; 30(6):1138-46.
    View in: PubMed
    Score: 0.174
  74. Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha agents in rheumatoid arthritis. Arthritis Rheum. 2003 Feb; 48(2):313-8.
    View in: PubMed
    Score: 0.170
  75. Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients. J Rheumatol. 2002 Dec; 29(12):2521-4.
    View in: PubMed
    Score: 0.168
  76. Satisfaction With a Virtual Learning Collaborative Aimed at Implementing Treat-to-Target in Rheumatoid Arthritis. J Clin Rheumatol. 2022 Aug 01; 28(5):265-269.
    View in: PubMed
    Score: 0.162
  77. Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: better treatments but a shortage of rheumatologists. Arthritis Rheum. 2002 Apr; 46(4):851-4.
    View in: PubMed
    Score: 0.160
  78. Implementing a Treat-to-Target Approach for Rheumatoid Arthritis During the COVID-19 Pandemic: Results of a Virtual Learning Collaborative Program. Arthritis Care Res (Hoboken). 2022 04; 74(4):572-578.
    View in: PubMed
    Score: 0.159
  79. Are long-term very low doses of prednisone for patients with rheumatoid arthritis as helpful as high doses are harmful?. Ann Intern Med. 2002 Jan 01; 136(1):76-8.
    View in: PubMed
    Score: 0.158
  80. Functional Status Measures and Indices in Rheumatoid Arthritis: Comment on the Articles by Barber et al and England et al. Arthritis Care Res (Hoboken). 2020 08; 72(8):1185-1186.
    View in: PubMed
    Score: 0.142
  81. Implementation of Treat-to-Target in Rheumatoid Arthritis Through a Learning Collaborative: Results of a Randomized Controlled Trial. Arthritis Rheumatol. 2017 07; 69(7):1374-1380.
    View in: PubMed
    Score: 0.115
  82. GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate. Rheumatology (Oxford). 2013 Oct; 52(10):1890-7.
    View in: PubMed
    Score: 0.088
  83. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis. 2011 Mar; 70(3):404-13.
    View in: PubMed
    Score: 0.074
  84. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum. 2011 Mar; 63(3):573-86.
    View in: PubMed
    Score: 0.074
  85. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010 Sep; 69(9):1580-8.
    View in: PubMed
    Score: 0.072
  86. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010 Sep; 62(9):2569-81.
    View in: PubMed
    Score: 0.072
  87. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report. Arthritis Rheum. 2010 Sep; 62(9):2582-91.
    View in: PubMed
    Score: 0.072
  88. Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis. J Rheumatol. 2010 Aug 01; 37(8):1633-8.
    View in: PubMed
    Score: 0.071
  89. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study. Arthritis Res Ther. 2010; 12(2):R42.
    View in: PubMed
    Score: 0.070
  90. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum. 2009 Nov 15; 61(11):1580-5.
    View in: PubMed
    Score: 0.068
  91. Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum. 2009 Jul; 60(7):1906-14.
    View in: PubMed
    Score: 0.066
  92. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther. 2009; 11(1):R7.
    View in: PubMed
    Score: 0.064
  93. Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries. Arthritis Rheum. 2008 Sep; 58(9):2642-51.
    View in: PubMed
    Score: 0.063
  94. Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis. Arthritis Rheum. 2008 Sep; 58(9):2662-9.
    View in: PubMed
    Score: 0.063
  95. Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum. 2008 Jul; 58(7):2105-12.
    View in: PubMed
    Score: 0.062
  96. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther. 2008; 10(2):R30.
    View in: PubMed
    Score: 0.060
  97. Physical inactivity in patients with rheumatoid arthritis: data from twenty-one countries in a cross-sectional, international study. Arthritis Rheum. 2008 Jan 15; 59(1):42-50.
    View in: PubMed
    Score: 0.060
  98. Increased augmentation index in rheumatoid arthritis and its relationship to coronary artery atherosclerosis. J Rheumatol. 2007 Dec; 34(12):2388-94.
    View in: PubMed
    Score: 0.059
  99. Quantitative measures of rheumatic diseases for clinical research versus standard clinical care: differences, advantages and limitations. Best Pract Res Clin Rheumatol. 2007 Aug; 21(4):601-28.
    View in: PubMed
    Score: 0.058
  100. Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis. Atherosclerosis. 2007 Dec; 195(2):e135-41.
    View in: PubMed
    Score: 0.057
  101. QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis. 2007 Nov; 66(11):1491-6.
    View in: PubMed
    Score: 0.057
  102. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis. 2008 Feb; 196(2):756-63.
    View in: PubMed
    Score: 0.056
  103. Shouldn't standard rheumatology clinical care be evidence-based rather than eminence-based, eloquence-based, or elegance-based? J Rheumatol. 2007 Jan; 34(1):1-4.
    View in: PubMed
    Score: 0.056
  104. An index of patient reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis. J Rheumatol. 2006 Nov; 33(11):2146-52.
    View in: PubMed
    Score: 0.055
  105. Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther. 2006; 8(6):R186.
    View in: PubMed
    Score: 0.052
  106. The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes. Arthritis Rheum. 2005 Dec; 52(12):3873-9.
    View in: PubMed
    Score: 0.052
  107. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum. 2005 Oct; 52(10):3045-53.
    View in: PubMed
    Score: 0.051
  108. Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate. J Rheumatol. 2004 Sep; 31(9):1723-6.
    View in: PubMed
    Score: 0.047
  109. The assessment of rheumatoid arthritis and the acceptability of self-report questionnaires in clinical practice. Arthritis Rheum. 2003 Feb 15; 49(1):59-63.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.